Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,200 HIV / AIDS
clinical trials

HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
Medical College of Georgia
mi
from
Augusta, GA
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
Western Penn Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling, Phase I
Updated: 12/31/1969
University Health Network-Princess Margaret Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
HIV Clinical Trial
Transmission Reduction Intervention Project
Status: Enrolling
Updated: 4/5/2016
Hellenic Scientific Society for the Study of AIDS and STDs
mi
from
Athens,
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Desmond Tutu HIV Foundation
mi
from
Cape Town,
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Cooper Univ. Hosp. CRS
mi
from
Camden, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Miami Infectious Disease Research Unit at Jackson Memorial Hospital CRS
mi
from
Miami, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Positive Health Clinic CRS
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Community AIDS Network/Comprehensive Care Clinic CRS
mi
from
Sarasota, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Toledo Medical Center CRS
mi
from
Toledo, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Oklahoma State University Center for Health Sciences CRS
mi
from
Tulsa, OK
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
HIV-1 Clinical Trial
Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected Children and Adolescents Virologically Suppressed on a 2-NRTI-Containing Regimen
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Hospital del Nino
mi
from
Panama City,
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Status: Enrolling, Phase I
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
HIV Infection Clinical Trial
Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients
Status: Enrolling, Phase
Updated: 12/31/1969
Methodist Health System
mi
from
Dallas, TX
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling, Phase
Updated: 12/31/1969
Greater Austin Allergy, Asthma, & Immunology
mi
from
Round Rock, TX
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigational site # 4902
mi
from
Frankfurt am Main,
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Baldwin Park, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1182.70.025 Chase Brexton Health Services, Inc
mi
from
Baltimore, MD
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1182.70.024
mi
from
Briarcliff Manor, NY
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1182.70.218 Denver Infectious Disease Consultants
mi
from
Denver, CO
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Panorama City, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1182.70.059 Fanno Creek Clinic
mi
from
Portland, OR
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Tarzana, CA
Click here to add this to my saved trials
HIV Clinical Trial
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling, Phase II, III
Updated: 12/31/1969
CD03 Investigational site
mi
from
Palm Springs, CA
Click here to add this to my saved trials
HIV Clinical Trial
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling, Phase II, III
Updated: 12/31/1969
CD03 Investigational site
mi
from
Wichita, KS
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
Dothan, AL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Hospital General de Agudos JM Ramos Mejía CRS
mi
from
Ciudad de Buenos Aires,
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling, Phase II
Updated: 12/31/1969
Georgetown HIVTR-CCR5 Non-Network CRS
mi
from
Washington DC,
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Status: Enrolling, Phase
Updated: 12/31/1969
5401 Puerto Rico AIDS Clinical Trials Unit CRS
mi
from
San Juan,
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Alcohol Research Consortium in HIV-Intervention Research Arm
Status: Enrolling, Phase IV
Updated: 12/31/1969
Harborview Medical Center; 2 West Clinic; UW Center for AIDS
mi
from
Seattle, WA
Click here to add this to my saved trials
Primary Immune Deficiency Diseases (PIDD) Clinical Trial
Study of PlasmaCap IG in Adults and Children With PIDD
Status: Enrolling, Phase III
Updated: 12/31/1969
CHU Ste-Justine ( Site 0084)
mi
from
Montreal,
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Rheumatology Clinical Trial
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Stanford University; Division of Pediatric Stem Cell Transplant & Regenerative Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
X-Linked Combined Immunodeficiency Diseases Clinical Trial
Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Laboratory of Host Defenses (LHD), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Section on Immunopathogenesis and Clinical Immunology
mi
from
Fairfax, VA
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: A Cardiac MRI Study
Status: Enrolling, Phase
Updated: 12/31/1969
University of Cape Town
mi
from
Cape Town,
Click here to add this to my saved trials
HIV INfections Clinical Trial
Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: A Cardiac MRI Study
Status: Enrolling, Phase
Updated: 12/31/1969
UTSW Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: A Cardiac MRI Study
Status: Enrolling, Phase
Updated: 12/31/1969
VA Medical Center-Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Immunologic Deficiency Syndromes Clinical Trial
Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Status: Enrolling, Phase III
Updated: 11/21/2017
Lysosomal Rare Disorder Research and Treatment Center, Inc.
mi
from
Fairfax, VA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
Status: Enrolling, Phase I
Updated: 12/31/1969
Zuckerberg San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
Status: Enrolling, Phase
Updated: 12/31/1969
Owen Clinic - University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Musculoskeletal, Psychiatry / Psychology Clinical Trial
MEMO-Medical Marijuana and Opioids Study
Status: Enrolling, Phase
Updated: 12/31/1969
Montefiore Health System
mi
from
Bronx, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Kentucky Bluegrass Care Clinic
mi
from
Lexington, KY
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Darlinghurst, Sydney,
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Rialto, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Wilton Manors, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
Status: Enrolling, Phase
Updated: 4/30/2018
Zuckerberg San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Effectiveness & Implementation of a Behavioral Intervention for Adherence and Substance Use in HIV Care in South Africa
Status: Enrolling
Updated: 12/31/1969
University of Cape Town
mi
from
Cape Town,
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Optimizing HIV Counseling and Testing and Referral Through an Adaptive Drug Use Intervention
Status: Enrolling
Updated: 12/31/1969
Center for Sexuality and Health Disparities
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
HIV INfections Clinical Trial
Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)- Positive Subjects From the LATTE Study
Status: Enrolling, Phase II
Updated: 12/31/1969
GSK Investigational Site
mi
from
Vancouver,
Click here to add this to my saved trials
Primary Immunodeficiency Disease Clinical Trial
Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Octapharma Research Site
mi
from
Frisco, TX
Click here to add this to my saved trials
Syphilis Clinical Trial
Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Washington - Harborview Medical Center - Center for AIDS and STD
mi
from
Seattle, WA
Click here to add this to my saved trials
Exposure to Human Immunodeficiency Virus (Event) Clinical Trial
What Happens in Vegas: PEP to PrEP Opportunities
Status: Enrolling, Phase
Updated: 12/31/1969
Huntridge Family Clinic
mi
from
Las Vegas, NV
Click here to add this to my saved trials
HIV INfections Clinical Trial
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Status: Upcoming, Phase III
Updated: 12/31/1969
Washington University Therapeutics (WT) CRS
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Personalized HIV and STI Testing Tool
Status: Upcoming
Updated: 12/31/1969
Bridge HIV, San Francisco Department of Public Health
mi
from
San Francisco, CA
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Alcohol Monitor Validation
Status: Upcoming
Updated: 12/31/1969
HealthStreet
mi
from
Gainesville, FL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Improving Health Outcomes in Young Men (mLab App)
Status: Upcoming
Updated: 12/31/1969
Columbia University School for Nursing
mi
from
New York, NY
Click here to add this to my saved trials
HIV INfections Clinical Trial
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Status: Upcoming, Phase III
Updated: 12/31/1969
Puerto Rico AIDS Clinical Trials Unit CRS
mi
from
San Juan,
Click here to add this to my saved trials
HIV (Human Immuno-Deficiency Virus) Clinical Trial
A Study of the Relative Bioavailability of BMS-626529 Administered as BMS-663068 (Prodrug) From 150mg Low-dose Extended-release Tablets Compared to 600mg Reference Extended-release Tablets in Healthy Subjects
Status: Upcoming, Phase I
Updated: 8/8/2016
Covance Dallas Clinical Research Unit
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Immunology / Infectious Diseases Clinical Trial
Impact of Providing Medical Records in a Patient-Centered, Community Pharmacy Based, HIV Care Model (HIV-MOI)
Status: Upcoming
Updated: 2/16/2018
University of North Texas
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Acute HIV Infection Clinical Trial
Empiric Treatment for Acute HIV in the ED
Status: Upcoming, Phase IV
Updated: 12/31/1969
Rand Schrader Health and Research Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
1 … 14 15 16 17 18 19 20 21 22